ADMA Biologics (ADMA) Announces $200M Capital Return Program Including $125M ASR Agreement

ADMA Biologics Inc. (NASDAQ:ADMA) is one of the best NASDAQ stocks under $30 to buy. On March 2, ADMA Biologics announced a significant capital return initiative for 2026, targeting a total of ~$200 million in share repurchases. As a primary component of this plan, the company entered into a $125 million ASR (accelerated share repurchase) agreement with JPMorgan Chase Bank. This move is supported by the company’s strong financial standing and sustained free cash flow. Under the specific terms of the ASR, ...